Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 57.00
High: 57.00
Low: 57.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

5 Apr 2018 18:23

RNS Number : 0367K
Maven Income & Growth VCT 4 PLC
05 April 2018
 

Maven Income and Growth VCT 4 PLC (the Company)

 

Issue of Equity

 

On 22 September 2017 the Company launched an offer for subscription for new ordinary shares of 10p each (Ordinary Shares) to raise up to £15 million, with an over-allotment facility for up to a further £5 million (the Offer). On the 2 March 2018 the Company announced that the Board of the Company had resolved to exercise its discretion to utilise the over-allotment facility of £5 million.

 

Pursuant to the Offer, and the £8,646,474.17 of valid applications received from 2 February 2018 until noon on 3 April 2018 in respect of the 2017/2018 tax year, the Company has issued and allotted 10,921,858 new Ordinary Shares on 5 April 2018. In accordance with the allotment formula set out in the prospectus for the Offer, the offer prices at which the shares were issued were in the range of 77.85p to 79.87p per Ordinary Share and, as a result, the number of Ordinary Shares now in issue is 53,539,342. Therefore, the total number of voting rights in the Company is 53,539,342.

 

In respect of this allotment, an application will be made by the Company to the UK Listing Authority and to the London Stock Exchange for the new Ordinary Shares so issued to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that the admission of the new Ordinary Shares will become effective and dealings will commence on or around 9 April 2018.

 

The above statement of Voting Capital may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The Board confirms that the Offer remains open for the 2018/2019 tax year and the Company intends that a final allotment in will take place on or before 20 April 2018.

 

For further information, please contact:

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Maven Capital Partners UK LLP

Secretary

 

5 April 2018

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUGUGPCUPRGMA
Date   Source Headline
7th Oct 20224:28 pmRNSPublication of a Prospectus
7th Oct 20229:58 amRNSDirector/PDMR Shareholding
7th Oct 20229:51 amRNSIssue of Equity
4th Oct 20223:30 pmRNSChange of Auditor
3rd Oct 20223:08 pmRNSStatement re Dividend Investment Scheme
6th Sep 20224:48 pmRNSTransaction in Own Shares
2nd Sep 20223:30 pmRNSHalf-year Report
19th Aug 202210:47 amRNSStatement re NAV and Interim Dividend
14th Jul 20229:33 amRNSDirectorate Change
8th Jul 20223:28 pmRNSStatement re Joint Offers for Subscription
24th Jun 20224:13 pmRNSDirectorate Change
9th Jun 20224:18 pmRNSTransaction in Own Shares
6th Jun 20222:15 pmRNSIssue of Equity
20th May 202210:09 amRNSDirector/PDMR Shareholding
20th May 202210:03 amRNSIssue of Equity
13th May 20223:24 pmRNSStatement re Dividend Investment Scheme
12th May 20223:19 pmRNSNet Asset Value(s)
11th May 20222:01 pmRNSResult of AGM & Directorate Change
26th Apr 202212:34 pmRNSIssue of Supplementary Prospectus
5th Apr 20226:30 pmRNSIssue of Equity
23rd Mar 20225:10 pmRNSDirector/PDMR Shareholding
23rd Mar 20225:05 pmRNSIssue of Equity
22nd Mar 20223:23 pmRNSAnnual Financial Report
16th Mar 20223:32 pmRNSTransaction in Own Shares
15th Mar 20223:09 pmRNSTransaction in Own Shares
11th Mar 202211:41 amRNSIssue of Equity - Dividend Investment Scheme
10th Mar 202211:30 amRNSIssue of Equity
10th Mar 202211:20 amRNSStatement re Dividend Investment Scheme
10th Mar 202211:04 amRNSNet Asset Value and Proposed Final Dividend
18th Feb 20225:32 pmRNSIssue of Equity - Replacement Announcement
7th Feb 202212:49 pmRNSDirector/PDMR Shareholding
7th Feb 202212:48 pmRNSDirector/PDMR Shareholding
7th Feb 202210:51 amRNSIssue of Equity
4th Feb 20229:46 amRNSNet Asset Value(s)
31st Jan 20224:25 pmRNSStatement re Offer for Suscription
10th Jan 202212:43 pmRNSStatement re Offer for Subscription
5th Jan 202210:35 amRNSDividend Declaration
2nd Dec 20213:37 pmRNSTransaction in Own Shares
11th Nov 20213:25 pmRNSNet Asset Value(s)
20th Oct 20214:44 pmRNSResult of General Meeting
1st Oct 20219:22 amRNSIssue of Equity
28th Sep 20213:22 pmRNSStatement re Dividend Investment Scheme
20th Sep 20215:42 pmRNSStatement re Change of Registrar
20th Sep 20215:21 pmRNSPublication of a Prospectus
7th Sep 20214:47 pmRNSTransaction in Own Shares
31st Aug 20213:27 pmRNSTransaction in Own Shares
27th Aug 20213:23 pmRNSHalf-year Report
24th Aug 20213:42 pmRNSTransaction in Own Shares
23rd Aug 20213:14 pmRNSTransaction in Own Shares
19th Aug 20213:04 pmRNSStatement re NAV and Interim Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.